SCHEMBL170572

SCHEMBL170572

CNCCCOc1cc(Cl)c(C)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 4/20 0.47
HTR1B P28222 2/20 0.44
L3MBTL4 Q8NA19 1/20 0.43
L3MBTL3 Q96JM7 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
HRH1 P35367 2/20 0.41
SLC6A4 P31645 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GAA P10253 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
RAF1 P04049 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171047 0.95 HTR1B (0.49) ALDH1A1KDM4EHTR1BL3MBTL4L3MBTL3
SCHEMBL171049 0.77 ALDH1A1 (0.44) ALDH1A1KDM4EHTR1BSMN1; SMN2GAA
SCHEMBL165584 0.76 RAF1 (0.42) ALDH1A1KDM4EHTR1BSMN1; SMN2LMNA
SCHEMBL13602320 0.76 CYP1A2 (0.47) ALDH1A1KDM4EHTR1BSMN1; SMN2LMNA
SCHEMBL22138644 0.75 ALDH1A1 (0.45) ALDH1A1KDM4ESMN1; SMN2LMNAL3MBTL1
SCHEMBL19828150 0.75 L3MBTL4 (0.65) ALDH1A1KDM4EL3MBTL4L3MBTL3SMN1; SMN2
SCHEMBL13602319 0.74 KDM4E (0.53) ALDH1A1KDM4EHTR1BSMN1; SMN2HRH1
SCHEMBL21595803 0.72 KDM4E (0.56) ALDH1A1KDM4EHTR1BSMN1; SMN2LMNA
SCHEMBL8003240 0.72 MAPT (0.59) ALDH1A1KDM4EL3MBTL4L3MBTL3SMN1; SMN2
SCHEMBL13602317 0.71 KDM4E (0.53) ALDH1A1KDM4ESMN1; SMN2LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426122-A1 Methylene urea derivative as RAF kinasse inhibitors Merck Patent GmbH (DE) 2012-03-07 EP disclosed